Xinping Ye
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 7
- Cancer, Lipids, and Metabolism 6
-
- RNA modifications and cancer 8
- Co-authors
- Tao Peng (47 shared papers)Guangzhi Zhu (41 shared papers)Ke Yang (3 shared papers)Chuangye Han (38 shared papers)Jian‐Hong Zhong (3 shared papers)Liang Ma (3 shared papers)Le‐Qun Li (4 shared papers)Bang‐De Xiang (2 shared papers)
In The Last Decade
Xinping Ye
53 papers receiving 1.1k citations
Xinping Ye's Hit Papers
Peers
Comparison fields: 5 of 75
- Hepatology 422
- Cancer Research 297
- Pulmonary and Respiratory Medicine 207
- Oncology 149
- Epidemiology 172
Countries citing papers authored by Xinping Ye
This map shows the geographic impact of Xinping Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinping Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinping Ye more than expected).
Fields of papers citing papers by Xinping Ye
This network shows the impact of papers produced by Xinping Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinping Ye. The network helps show where Xinping Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinping Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma Hit paper breakdown → | 2013 | 354 |
| 2 | 2020 | 136 | |
| 3 | 2018 | 52 | |
| 4 | 2014 | 43 | |
| 5 | 2019 | 39 | |
| 6 | 2018 | 34 | |
| 7 | 2019 | 32 | |
| 8 | 2018 | 29 | |
| 9 | 2022 | 26 | |
| 10 | 2013 | 25 | |
| 11 | 2019 | 25 | |
| 12 | 2021 | 24 | |
| 13 | 2020 | 19 | |
| 14 | 2017 | 18 | |
| 15 | 2016 | 18 | |
| 16 | 2019 | 18 | |
| 17 | 2018 | 17 | |
| 18 | 2019 | 15 | |
| 19 | 2019 | 14 | |
| 20 | 2021 | 13 |
About Xinping Ye
Xinping Ye is a scholar working on Cancer Research, Molecular Biology, Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Ferroptosis and cancer prognosis (8 papers), Pancreatic and Hepatic Oncology Research (8 papers), RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers), Cancer, Lipids, and Metabolism (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Hepatology (422 citations), Cancer Research (297 citations), Pulmonary and Respiratory Medicine (207 citations), Oncology (149 citations) and Epidemiology (172 citations). Xinping Ye has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Tao Peng, Guangzhi Zhu, Ke Yang, Chuangye Han, Jian‐Hong Zhong, Liang Ma, Le‐Qun Li, Bang‐De Xiang, Gui‐Sheng Xie and Wen‐Feng Gong. Their work appears in journals such as Journal of Cancer, Oncology Reports, Cancer Medicine, Cancer Management and Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.